Company Analysis

Eton Pharmaceuticals, Inc. (ETON)

Nasdaq: ETON · Pharmaceutical Preparations · Deer Park, IL · filing with the SEC since 2017
Grade5.7
◀ Past 5.1● Present 6.6▶ Future 5.1

Who runs Eton Pharmaceuticals, Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Brynjelsen Sean
President & CEO. First filing Nov 2018, latest Aug 20, 2026, 9 filings in all.
Officers reporting now
6
of 10 people with a filing in the last fifteen months
Directors reporting now
4
12 people on the record since 2018
Officerssales are open-market, Nov 12, 2025 to Nov 12, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Erdogan-Trinkaus IpekChief Commercial OfficerDec 2024Nov 12, 20262 · $200,000
Krempa DavidChief Business OfficerMar 2023Oct 6, 20267 · $5.1M
Brynjelsen SeanPresident & CEONov 2018Aug 20, 20266 · $9.9M
Radosavljevic DankaChief Operating OfficerAug 2026Aug 12, 2026none
Matthews Judith M.Chief Financial OfficerJun 2026Aug 4, 2026none
Gruber James R.Chief Financial OfficerApr 2022Jan 14, 2026none
Directorssales are open-market, Nov 12, 2025 to Nov 12, 2026
NameRoleFirst filingLatest filingSales, 12 months
Casamento Charles JdirectorNov 2018Nov 10, 20265 · $5.3M
Maier Paul VdirectorNov 2018Aug 31, 20266 · $5.9M
Adams Jennifer MckiedirectorMar 2021Aug 4, 20261 · $1.6M
Riedel Norbert GdirectorNov 2018Aug 4, 2026none
Owners of more than 10% of a classsales are open-market, Nov 12, 2025 to Nov 12, 2026
NameRoleFirst filingLatest filingSales, 12 months
Opaleye Management Inc.10% ownerApr 2020Jul 17, 20269 · $6.9M
Earlier names on the record3, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton ETON · research, not advice